Caribou Biosciences, Inc. Quarterly Operating Margin in % from Q4 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Caribou Biosciences, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q3 2024.
  • Caribou Biosciences, Inc. Operating Margin for the quarter ending September 30, 2024 was -1.44K %, a 356% decline year-over-year.
  • Caribou Biosciences, Inc. annual Operating Margin for 2023 was -337 %, a 56.2% increase from 2022.
  • Caribou Biosciences, Inc. annual Operating Margin for 2022 was -768 %, a 10.1% decline from 2021.
  • Caribou Biosciences, Inc. annual Operating Margin for 2021 was -698 %, a 139% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -1.44K -1.12K -356% Jul 1, 2024 Sep 30, 2024
Q2 2024 -428 +422 +49.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -392 +402 +50.6% Jan 1, 2024 Mar 31, 2024
Q4 2023 -337 +432 +56.2% Oct 1, 2023 Dec 31, 2023
Q3 2023 -315 +441 +58.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 -850 -190 -28.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 -794 -83.9 -11.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -768 -58 -8.17% Oct 1, 2022 Dec 31, 2022
Q3 2022 -757 +28.2 +3.59% Jul 1, 2022 Sep 30, 2022
Q2 2022 -659 +343 +34.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -710 -393 -124% Jan 1, 2022 Mar 31, 2022
Q4 2021 -710 -418 -143% Oct 1, 2021 Dec 31, 2021
Q3 2021 -785 Jul 1, 2021 Sep 30, 2021
Q2 2021 -1K Apr 1, 2021 Jun 30, 2021
Q1 2021 -317 Jan 1, 2021 Mar 31, 2021
Q4 2020 -292 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.